EBITDA: Income before interest, taxes, depreciation and amortization.
Quantum Biopharma Ltd. (V.QNT) had EBITDA of -6.25M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-7.33M |
|
-- |
|
-- |
|
-- |
|
-6.44M |
|
-- |
|
-6.54M |
|
-6.54M |
|
-6.54M |
|
-6.54M |
|
-6.54M |
|
-6.54M |
|
-6.44M |
|
|
EBITDA |
-6.25M |
3.80M |
|
3.80M |
|
-1.93 |
|
-1.93 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
19.50M |
|
-- |
|
-- |
|
-- |
|
9.16M |
|
10.34M |
|
3.98M |
|
10.34M |
|
3.82M |
|
| Cash Flow Statement Financials | |
-10.93M |
|
-3.17M |
|
6.45M |
|
8.26M |
|
0.61M |
|
-7.65M |
|
2.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-63.24% |
|
-164.42% |
|
-33.54% |
|
-63.24% |
|
2.71 |
|
-2.87 |
|
-2.87 |
|